Ireland's Department of Health has resolved outstanding concerns over the availability of flu vaccines

NewsGuard 100/100 Score

The Ireland's Department of Health has resolved outstanding concerns over the availability of flu vaccines and has secured commitments from new suppliers that will fully meet Ireland’s needs this winter.

Not withstanding a problem with one supplier that affected supplies worldwide, almost 598,000 doses have now been secured for Ireland. The national demand is for 530,000 doses.

200,000 doses of flu vaccine were distributed around the country in early September. 89,000 doses are currently being distributed and a further 103,680 doses will arrive in the country on Thursday next. This will bring the total received by the end of this week to 392,680. This compares favourably to last year - at this time last year 329,400 doses had been distributed. A further 200,000 doses will be delivered later this month.

The Department of Health and Children asked Health Boards on 23rd September to advise GP’s to concentrate their efforts on ensuring that patients at greatest risk receive priority vaccination.

Any remaining local difficulties with flu vaccine supply should be greatly eased by the end of this week.

http://www.doh.ie

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Promising influenza drug candidate shows activity against resistant variants